Alpha-Fetoprotein Antigen (AFP), Recombinant

$0.00

Alpha-Fetoprotein Antigen (AFP), Recombinant | Cat# A1006

Product Description:
Recombinant Alpha-Fetoprotein (AFP) – Cat# A1006 – is a high-purity tumor marker antigen produced through advanced recombinant expression systems. AFP is a fetal glycoprotein typically produced by the liver and yolk sac, widely used as a biomarker in hepatocellular carcinoma, germ cell tumors, and fetal development studies. This recombinant form offers superior consistency and purity, making it ideal for use in immunoassays, diagnostic kit manufacturing, and cancer biomarker research.

Key Features:

  • Recombinant form ensures high consistency and purity

  • Ideal for ELISA, western blotting, and tumor marker assays

  • Suitable for oncology, hepatology, and prenatal research applications

Applications:

  • Development and calibration of AFP immunoassays

  • Diagnostic quality controls for cancer screening

  • Research in liver cancer and fetal health biomarkers

Alpha-Fetoprotein Antigen (AFP), Recombinant | Cat# A1006

Product Description:
Recombinant Alpha-Fetoprotein (AFP) – Cat# A1006 – is a high-purity tumor marker antigen produced through advanced recombinant expression systems. AFP is a fetal glycoprotein typically produced by the liver and yolk sac, widely used as a biomarker in hepatocellular carcinoma, germ cell tumors, and fetal development studies. This recombinant form offers superior consistency and purity, making it ideal for use in immunoassays, diagnostic kit manufacturing, and cancer biomarker research.

Key Features:

  • Recombinant form ensures high consistency and purity

  • Ideal for ELISA, western blotting, and tumor marker assays

  • Suitable for oncology, hepatology, and prenatal research applications

Applications:

  • Development and calibration of AFP immunoassays

  • Diagnostic quality controls for cancer screening

  • Research in liver cancer and fetal health biomarkers

 
Alpha-Fetoprotein Antigen (AFP)

Testing:

This material has been tested for HIV 1/2, HIV-1 (NAT), HBsAg, HBV (NAT), HCV, HCV (NAT), and RPR by FDA approved methods and found to be NON-REACTIVE.

Intended Use and Customer Responsibility

Golden West BioSolutions, LLC products are specifically designed for research and the manufacturing of non-injectable products. It is the customer's responsibility to handle these products safely and responsibly. Golden West BioSolutions, LLC is not liable for any injuries stemming from the use or handling of its products. All disposal procedures must align with federal and state regulations.

Quality Assurance Disclaimer

Golden West BioSolutions, LLC does not warrant the performance of their products in specific applications. Customers are responsible for determining the suitability and qualification of Golden West BioSolution products for their intended use. Given the natural variation in biological materials, Golden West BioSolutions, LLC also recommends consideration of lot-to-lot evaluation.